M 439 1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-uracil |
|
(FAU) Non-labeled | |
MORpure™ Delivered 98% pure with dated HPLC UV chromatogram |
|
Solid | 1 mg $215 |
Screw cap v-vial | 5 mg $565 |
M.W. 246.19 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MC 439 1-(2-Deoxy-2-fluoro-ß-D-arabinofuranosyl)-uracil, [2-14C]- |
|
(FAU, [2-14C]-) | |
MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
Ethanol solution, 100 µCi/ml | 10 µCi (370 kBq) $1240 |
> 45 mCi(1.665 GBq)/mmol | 50 µCi (1.85 MBq) $3970 |
NextGen V-Vial - shipped on dry ice | |
M.W. 246.19 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |
MT 1778 1-(2-Deoxy-2-fluoroarabinofuranosyl)-uracil, [5-3H]- |
|
(FAU, [5-3H]-) | |
MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram |
|
Ethanol:water (1:1) solution, 1 mCi/ml | |
> 5 Ci(185 GBq)/mmol | 50 μCi (1.85 MBq) $1160 |
NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $1970 |
M.W. 246.19 | |
This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. |